PANK-003 Cell Injection

PANK-003 · Shenzhen Celconta Life Science Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PANK-003 Cell Injection, covering 2025-03-26 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC [Phase 2]

See pricing